Back

Overall benefits of smoking cessation in patients with ASCVD are underestimated

7 April 2022 (17:41 - 17:50)
Organised by:
Congress Presentation Part of: Moderated posters session 1 - Secondary Prevention and Rehabilitation Cardiovascular Risk Assessment, Other EAPC Premium Access ESC Preventive Cardiology 2022

About the speaker

Photo
Ms Tinka Van Trier

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
The most important safety risk of fish oil from the latest meta-analysis?
Mr J. Yan (CN)
Abstract Slides
Presentation thumbnail
The efficacy of high-load resistance training in combination with aerobic training in patients with coronary artery disease: a dose-dependent randomised, controlled clinical trial
Mr T. Kambic (Ljubljana, SI)
Abstract Slides
Presentation thumbnail
Exercise training modalities for heart transplant recipients: A systematic review and network meta-analysis
Presentation thumbnail
Novel equation for skeletal muscle mass estimation is useful for predicting mortality in patients with heart failure
Mr S. Honma (Sapporo, JP)
Abstract Slides

Access the full session

Session thumbnail
Moderated posters session 1 - Secondary Prevention and Rehabilitation

The Event

Event poster

ESC Preventive Cardiology 2022

7 April 2022 17:41 CET
You may be interested in
thumbnail
Congress Presentation
Predicted lifetime therapy benefit guided treatment effectively reduces residual cardiovascular risk in patients with symptomatic atherosclerotic disease
29 August 2020
thumbnail
Congress Presentation
The smoker's paradox: early-onset ACS in active smokers
20 March 2026
thumbnail
Congress Presentation
The effects of cytisinicline for smoking cessation on arterial stiffness, endothelial function and myocardial performance: a pilot study
30 August 2025
thumbnail
Congress Presentation
INTERASPIRE a global cross-sectional survey of secondary prevention of cardiovascular disease (CVD) across six WHO regions
15 June 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources